Integra Lifesciences Holdings Corp
IART - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.04B
Close$
$34.10
136.8% upside
Current Fair Value
136.8% upsideUndervalued by 136.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.04 Billion |
|---|---|
| Enterprise Value | $2.81 Billion |
| Earnings per Share | $-6.73 |
| Beta | 1.28 |
| Outstanding Shares | 78,577,000 |
Return
| Return on Equity | 1.22% |
|---|---|
| Return on Assets | 0.37% |
| Return on Invested Capital | 4.23% |
Valuation & Multiples
| P/E Ratio | 79.98 |
|---|---|
| PEG | -21.34 |
| Price to Sales | 0.69 |
| Price to Book Ratio | 1.11 |
| Enterprise Value to Revenue | 1.7 |
| Enterprise Value to EBIT | 20.9 |
| Enterprise Value to Net Income | 215 |
| Total Debt to Enterprise | 0.72 |
| Debt to Equity | 1.89 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
$0.56
Consensus analyst estimateRevenue Estimate
$415.36 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 25, 2027
EPS Estimate
$0.69
Consensus analyst estimateRevenue Estimate
$422.37 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 10.54%▼ 86.54% |
|---|---|
| Total Invested | $134.13M▼ 90.00% |
| Investors Holding | 86▼ 127.00% |
About Integra Lifesciences Holdings Corp
CEO: Peter Arduini
